Kern Ralph Dr. 4/A
4/A · BRAINSTORM CELL THERAPEUTICS INC. · Filed Mar 20, 2018
Insider Transaction Report
Form 4/AAmended
Kern Ralph Dr.
COO and Chief Medical Officer
Transactions
- Purchase
Common Stock
2018-03-15$3.60/sh+5,000$17,997→ 40,885 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.59 to $3.60, inclusive. The reporting person undertakes to provide to Brainstorm Cell Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]This Form 4/A is being filed to reflect that this transaction was an open market purchase of the Issuer's securities (on March 19, 2018 this transaction was incorrectly reported on Form 4 as an acquisition pursuant to Rule 16b-3(d)).